VTAL — Justera Health Income Statement
0.000.00%
- CA$1.24m
- CA$0.79m
- CA$1.91m
- 13
- 40
- 16
- 11
Annual income statement for Justera Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 13 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 21.2 | 14.7 | 1.91 |
Cost of Revenue | |||||
Gross Profit | — | — | 2.7 | 2.58 | 0.857 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.052 | 0.072 | 31.4 | 19.9 | 5.07 |
Operating Profit | -0.052 | -0.072 | -10.2 | -5.25 | -3.15 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.052 | -0.072 | -10.2 | -5.25 | -3.02 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.052 | -0.072 | -10.2 | -5.25 | -2.98 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.052 | -0.072 | -10.2 | -5.25 | -2.98 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.052 | -0.072 | -10.2 | -5.25 | -2.98 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | -0.002 | -0.118 | -0.045 | -0.027 |
Dividends per Share |